Nevertheless, there is ongoing clinical interest, and early-phase clinical trials targeting TNF signaling in PD and RBD are underway (https://clinicaltrials.gov/study/NCT06996652)16, underscoring the need for robust human genetic evidence to support or refute this therapeutic strategy. Here, TNF is linked to Parkinson disease.